Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 9/2/09 AVI BioPharma, Inc. Presenting at Rodman & Renshaw Global Investment Conference 8/27/09 AVI BioPharma, Inc. To Present Leading PPMO Drug Delivery Technology at Upcoming Scientific Meetings 8/25/09 AVI BioPharma Phase 1 Proof of Concept and Safety Data for AVI-4658 in Duchenne Muscular Dystrophy Featured in Lancet Neurology 8/25/09 AVI BioPharma to Present Safety Data in Duchenne Muscular Dystrophy at 14th Annual International Congress of the World Muscle Society 8/25/09 AVI BioPharma Announces Closing of Public Offering of Common Stock and Warrants 8/20/09 AVI BioPharma, Inc. Announces Proposed Public Offering of Common Stock and Warrants 8/19/09 AVI BioPharma, Inc. Announces Proposed Public Offering of Common Stock and Warrants 8/10/09 AVI BioPharma Announces Second Quarter 2009 Financial Results & Corporate Highlights 8/3/09 AVI BioPharma Announces Second Quarter 2009 Financial Results Conference Call 7/31/09 AVI BioPharma, Inc. Files Shelf Registration Statement Pagination First page « first Previous page ‹ previous … Page 63 Page 64 Page 65 Page 66 Current page 67 Page 68 Page 69 Page 70 Page 71 … Next page next › Last page last » Displaying 661 - 670 of 816 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 9/2/09 AVI BioPharma, Inc. Presenting at Rodman & Renshaw Global Investment Conference 8/27/09 AVI BioPharma, Inc. To Present Leading PPMO Drug Delivery Technology at Upcoming Scientific Meetings 8/25/09 AVI BioPharma Phase 1 Proof of Concept and Safety Data for AVI-4658 in Duchenne Muscular Dystrophy Featured in Lancet Neurology 8/25/09 AVI BioPharma to Present Safety Data in Duchenne Muscular Dystrophy at 14th Annual International Congress of the World Muscle Society 8/25/09 AVI BioPharma Announces Closing of Public Offering of Common Stock and Warrants 8/20/09 AVI BioPharma, Inc. Announces Proposed Public Offering of Common Stock and Warrants 8/19/09 AVI BioPharma, Inc. Announces Proposed Public Offering of Common Stock and Warrants 8/10/09 AVI BioPharma Announces Second Quarter 2009 Financial Results & Corporate Highlights 8/3/09 AVI BioPharma Announces Second Quarter 2009 Financial Results Conference Call 7/31/09 AVI BioPharma, Inc. Files Shelf Registration Statement Pagination First page « first Previous page ‹ previous … Page 63 Page 64 Page 65 Page 66 Current page 67 Page 68 Page 69 Page 70 Page 71 … Next page next › Last page last » Displaying 661 - 670 of 816